Key result
The type of valve prosthesis implanted (bioprosthesis versus metallic) had no significant influence on in-hospital mortality (p=0.915) in patients undergoing valve replacement surgery.
Why the study?
Does the type of valve prosthesis (bioprosthesis vs. metallic) influence early in-hospital mortality in patients undergoing valve replacement surgery?
Cross-Sectional (n=353)
No
Does the type of valve prosthesis (bioprosthesis vs. metallic) influence early in-hospital mortality in patients undergoing valve replacement surgery?
In a retrospective analysis of patients undergoing valve replacement, the choice between bioprosthetic and metallic valves did not significantly affect early in-hospital mortality.
Valve choice was not associated with in-hospital mortality; leaves open optimal prosthesis selection pending prospective trials.
OBJECTIVE: To evaluate the influence of the type of prosthesis in-hospital mortality in the post-operative period in patients who had valve replacement. METHODS: A cross-sectional data, such as gender, origin, age, etiology, echocardiograph data, the type of surgery performed and the prosthesis used in cases of valve replacement were analyzed retrospectively. RESULTS: We reviewed 353 charts of patients who underwent valve replacement surgery. The mean age was 41.87±17.9 years. Regarding gender, 52.8% were female. As for the origin, 61.1% came from small cities within the state. Of all patients, 58.5% suffered from rheumatic disease. Assessing the type of prosthesis implanted, 70% held replace by bioprosthesis and 30% metallic. The hospital mortality in this study was 11%, with no significant difference between the types of prosthesis utilized. CONCLUSION: The type of implant used had no effect on in-hospital mortality.
No takes yet. Share an insight, caveat, or question.
Fernandes et al. (2014) conducted a cross-sectional in Valvular heart disease (n=353). Bioprosthesis vs. Metallic prosthesis was evaluated on In-hospital mortality (p=0.915). The type of valve prosthesis implanted (bioprosthesis versus metallic) had no significant influence on in-hospital mortality (p=0.915) in patients undergoing valve replacement surgery.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: